BeiGene nears finish on landmark Star IPO

BeiGene is on the verge of wrapping up the largest ever biotechnology IPO on Shanghai’s Nasdaq-style Star board, with institutional and retail investors both vying for shares on Thursday. BeiGene is ... ( read original story ...)

Positives may beat scare in stock market

China's A-share market has largely withstood the shock of the new COVID-19 variant named Omicron on Monday, which the World Health Organization designated as "a variant of concern". The Shanghai ... ( read original story ...)